CIAM
KPRX icon

Caitong International Asset Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Caitong International Asset Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12 Buy
+6
New +$13 ﹤0.01% 2123

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caitong International Asset Management's KPRX Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Kiora Pharmaceuticals (KPRX) in Q1 2026: 6 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #2123 among its holdings.

18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • Caitong International Asset Management held 6 shares of Kiora Pharmaceuticals worth $12 as of Q1 2026.
  • Kiora Pharmaceuticals was a new Caitong International Asset Management position in Q1 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2123 holding.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.